找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbuch Wissenschaftspolitik; Dagmar Simon,Andreas Knie,Karin Zimmermann Living reference work 20200th edition

[復(fù)制鏈接]
21#
發(fā)表于 2025-3-25 05:04:03 | 只看該作者
Karl Ulrich Mayerathogenesis.Includes supplementary material: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.? While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid adva
22#
發(fā)表于 2025-3-25 07:32:05 | 只看該作者
Jürgen Endersathogenesis.Includes supplementary material: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.? While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid adva
23#
發(fā)表于 2025-3-25 13:59:50 | 只看該作者
24#
發(fā)表于 2025-3-25 19:35:47 | 只看該作者
25#
發(fā)表于 2025-3-25 23:07:43 | 只看該作者
26#
發(fā)表于 2025-3-26 01:07:58 | 只看該作者
27#
發(fā)表于 2025-3-26 04:26:59 | 只看該作者
Uwe Schimankathogenesis.Includes supplementary material: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.? While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid adva
28#
發(fā)表于 2025-3-26 10:02:02 | 只看該作者
29#
發(fā)表于 2025-3-26 14:06:18 | 只看該作者
Albrecht Blümelathogenesis.Includes supplementary material: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.? While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid adva
30#
發(fā)表于 2025-3-26 19:23:07 | 只看該作者
Andreas Knie,Dagmar Simonathogenesis.Includes supplementary material: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course.? While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid adva
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 15:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永嘉县| 江达县| 万山特区| 广河县| 英德市| 贵南县| 南阳市| 霍林郭勒市| 安岳县| 青州市| 休宁县| 蓬莱市| 房山区| 合川市| 海安县| 闻喜县| 梁平县| 恭城| 安仁县| 政和县| 甘泉县| 江西省| 临城县| 西畴县| 东乌| 桦南县| 盐津县| 修武县| 福海县| 茶陵县| 容城县| 城口县| 左贡县| 阿勒泰市| 新余市| 临夏市| 文安县| 长乐市| 成武县| 都兰县| 泽普县|